Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | VP, Clinical Affairs | February 20, 2023 | February 23, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date February 20, 2023 · Filed February 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,685 |
Reported balance
After 2023-02-20 transaction · row 1
1 source rowRow 1 · 2023-02-20 · Grant · Acquired 5,685 · Balance 5,685 F1: Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.10 · Expires 2033-02-20 | Direct | 8,705 |
Reported balance
After 2023-02-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-02-20 · Grant · Acquired 8,705 · Balance 8,705 F2: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 8,705 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005897 · doc4.xml · derivative · entry 2 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,705 Underlying: Common Stock · 8,705 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 5,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005897 · doc4.xml · nonDerivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,685 F1 · shares: Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,740 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 9 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,063 Underlying: Common Stock · 4,740 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 8 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,803 Underlying: Common Stock · 250 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,740 | $58.96 | $279,470.40 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 6 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $58.92 to $59.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 4,740 | $38.46 | $182,300.40 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 5 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 250 | $60.02 | $15,005.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 4 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 250 | $38.46 | $9,615.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 3 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,947 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 7 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,053 Underlying: Common Stock · 5,947 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,947 | $62.43 | $371,271.21 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 2 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.00 to $62.91, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,947 | $38.46 | $228,721.62 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:48 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000899243-22-007683 · doc4.xml · derivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:43 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008443 · doc4.xml · derivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 27, 2020 Filed Mar 6, 2020 23:11 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-20-007513 · doc4.xml · derivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 22:01 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $21.89 | $0.00 |
DisclosureSEC source: 0000899243-19-021276 · doc4.xml · derivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2029-08-05 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the vesting commencement date, August 1, 2019, and as to the remaining shares in equal monthly installments over three years thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.